Live Breaking News & Updates on Advanced Gastric

Stay updated with breaking news from Advanced gastric. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BeiGene Presents New Research from Tislelizumab Global Development Program at 2023 ASCO Gastrointestinal Cancers Symposium

Oral presentation for RATIONALE 305 showed improved survival and manageable safety profile for tislelizumab and chemotherapy in gastric or gastroesophageal junction cancer with PD-L1 expression BeiGene ....

China , Beijing , Cambridge , Cambridgeshire , United-kingdom , United-states , America , Kevin-mannix , Mark-lanasa , Kyle-blankenship , Exchange-commission , European-union

CARsgen Therapeutics Presents Updated Data for CT041 Claudin18.2 CAR T-cells in Solid Tumors at ASCO 2022

SHANGHAI, June 6, 2022 /PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell the. ....

China , Shanghai , United-states , Canada , Chinese , America , American , Raffaele-baffa , Zonghai-li , American-society-of-clinical-oncology , Carsgen-therapeutics-holdings , Prnewswire-carsgen-therapeutics-holdings-limited-stock-code

ALX Oncology (ALXO) Announces Evorpacept Clinical Program Updates

ALX Oncology (ALXO) Announces Evorpacept Clinical Program Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Sophia-randolph , Eli-lilly , Jaume-pons , Drug-administration , Nasdaq , Oncology-holdings-inc , Holdings-inc , Urothelial-carcinoma , Chief-executive-officer , Acute-myeloid-leukemia

Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy Response for More Patients

/PRNewswire/ Exact Sciences Corp. (NASDAQ: EXAS) and OncXerna Therapeutics, Inc., a precision medicine company, announced today they have entered an. ....

Ashleyr-robinson , Matt-franklin , Stephanie-spanos , Laura-benjamin , Megan-jones , Precision-oncology-for-exact-sciences , Sciences-corp , Lifesci-partners , Sciences-on-twitter-exactsciences , Nasdaq , Oncxerna-therapeutics-inc

Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy Response for More Patients

/PRNewswire/ Exact Sciences Corp. (NASDAQ: EXAS) and OncXerna Therapeutics, Inc., a precision medicine company, announced today they have entered an. ....

Ashleyr-robinson , Matt-franklin , Stephanie-spanos , Laura-benjamin , Megan-jones , Precision-oncology-for-exact-sciences , Sciences-corp , Lifesci-partners , Sciences-on-twitter-exactsciences , Nasdaq , Oncxerna-therapeutics-inc